Malignant tumors found in children are different from the ones that occur in adults.
Compared to the malignancies in adults, the histological entities in pediatric patients
are different and survival rates are higher among the children. Though pediatric soft
tissue sarcomas are less common than leukemia and central nervous system malignancies,
recognition of them is necessary to start the therapy as soon as possible. The delay
of an appropriate treatment - chemotherapy, radiotherapy, surgery, in some cases targeted
therapy - is unfavorable because somatic damages and functional loss can occur. In
our study at the oncology department of the 2nd Department of Pediatrics of Semmelweis
University, we collected and analyzed the data of 90 children who were diagnosed with
soft tissue sarcomas between January of 2000 and November of 2016. Our results correlate
with the data collected worldwide.
